BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28641098)

  • 1. Trends in hematopoietic stem cell transplant activity in Lebanon.
    Bazarbachi A; Zahreddine A; Massoud R; El Cheikh J; Hanna C; Nasr F; Abboud M; Ibrahim A
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):315-320. PubMed ID: 28641098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
    Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
    Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic hematopoietic stem cell transplantation in congenital disorders: A single-center experience.
    Faraci M; Giardino S; Bagnasco F; Morreale G; Terranova MP; Di Martino D; Lanino E
    Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28649784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations.
    Niederwieser C; Starke S; Fischer L; Krahl R; Beck J; Gruhn B; Ebell W; Körholz D; Wößmann W; Bader P; Lang P; Al-Ali HK; Cross M; Eisfeld AK; Heyn S; Vucinic V; Franke GN; Lange T; Pönisch W; Behre G; Christiansen H
    Ann Hematol; 2016 Feb; 95(3):473-81. PubMed ID: 26696465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation group.
    Hussein AA; Hamidieh AA; Elhaddad A; Ramzi M; Othman TB; Hussain F; Dennison D; Ahmed P; Abboud M; Al-Ahmari A; Wahadneh A; Fathy J; Bekadja MA; Al-Kindi S; Benchekroun S; Ibrahim A; Behfar M; Samra M; Ladeb S; Adil S; El-Solh H; Ayas M; Aljurf M; Ghavamzadeh A; Al-Seraihy A;
    Bone Marrow Transplant; 2017 Jan; 52(1):120-125. PubMed ID: 27618684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase.
    Yu SC; Huang HH; Li CC; Tang JL; Lee YH; Mao TL; Kuo KT; Lin CT; Liu JH; Ko BS; Yao M
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1367-1373. PubMed ID: 28450182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in pediatric hematopoietic stem cell transplantation.
    Barfield RC; Kasow KA; Hale GA
    Cancer Biol Ther; 2008 Oct; 7(10):1533-9. PubMed ID: 18927494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.
    Passweg JR; Baldomero H; Bader P; Bonini C; Duarte RF; Dufour C; Gennery A; Kröger N; Kuball J; Lanza F; Montoto S; Nagler A; Snowden JA; Styczynski J; Mohty M
    Bone Marrow Transplant; 2017 Jun; 52(6):811-817. PubMed ID: 28287639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children.
    Jacobsohn DA; Duerst R; Tse W; Kletzel M
    Lancet; 2004 Jul 10-16; 364(9429):156-62. PubMed ID: 15246728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EBMT activity survey 2009: trends over the past 5 years.
    Baldomero H; Gratwohl M; Gratwohl A; Tichelli A; Niederwieser D; Madrigal A; Frauendorfer K;
    Bone Marrow Transplant; 2011 Apr; 46(4):485-501. PubMed ID: 21358689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.
    Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003.
    Gratwohl A; Baldomero H; Schmid O; Horisberger B; Bargetzi M; Urbano-Ispizua A
    Bone Marrow Transplant; 2005 Oct; 36(7):575-90. PubMed ID: 16086045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation.
    Passweg JR; Baldomero H; Peters C; Gaspar HB; Cesaro S; Dreger P; Duarte RF; Falkenburg JH; Farge-Bancel D; Gennery A; Halter J; Kröger N; Lanza F; Marsh J; Mohty M; Sureda A; Velardi A; Madrigal A;
    Bone Marrow Transplant; 2014 Jun; 49(6):744-50. PubMed ID: 24637898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres.
    Poirel HA; Vanspauwen M; Macq G; De Geyndt A; Maertens J; Willems E; Selleslag D; Poiré X; Theunissen K; Graux C; Kerre T; Zachée P; Meuleman N; De Becker A; Verlinden A; Van Obbergh F; Schuermans C; De Wilde V; Jaspers A; Pranger D; Deeren D; Van Riet I; Vaes E; Beguin Y;
    Bone Marrow Transplant; 2019 Sep; 54(9):1434-1442. PubMed ID: 30696999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the EBMT activity survey in the management of hematopoietic stem cell transplantation. European Group for Blood Marrow Treansplantation.
    Gratwohl A
    Int J Hematol; 2002 Aug; 76 Suppl 1():386-92. PubMed ID: 12430888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
    Gratwohl A; Baldomero H; Frauendorfer K; Rocha V; Apperley J; Niederwieser D; ;
    Bone Marrow Transplant; 2008 Apr; 41(8):687-705. PubMed ID: 18084334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell transplantation in Lebanon: first comprehensive report.
    Bazarbachi A; Hatoum H; Mugharbel A; Otrock Z; Yassine N; Muwakkit S; Salem Z; Shebbo W; Jisr T; Abboud M; Ibrahim A
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S96-S102. PubMed ID: 18724316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical developments in reduced intensity haematopoietic stem cell transplantation.
    Hogan WJ; Storb R
    Expert Opin Biol Ther; 2002 Oct; 2(7):703-14. PubMed ID: 12387669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation in the Sultanate of Oman.
    Al-Khabori M; Al-Huneini M
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):305-307. PubMed ID: 28648947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey.
    Gratwohl A; Baldomero H; Passweg J; Urbano-Ispizua A;
    Bone Marrow Transplant; 2002 Dec; 30(12):813-31. PubMed ID: 12476273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.